98%
921
2 minutes
20
Objective: This study aims to explore the neuroprotective effects of Dl-3-n-Butylphthalide (NBP) against cerebral ischemia-reperfusion injury (CIRI), with a focus on NBP's underlying molecular mechanism.
Methods: A CIRI rat model was established, followed by treatment with NBP with/without microRNA-20a-5p (miR-20a-5p) mimic or negative control. Neurological deficits, brain infarct size, and histopathological changes were assessed. In vitro, an oxygen-glucose deprivation/reoxygenation (OGD/R)-induced PC12 cell model was developed, followed by cell viability and apoptosis evaluation. miR-20a-5p, X-linked inhibitor of apoptosis protein (XIAP), and apoptosis-related protein levels were detected. A dual-luciferase reporter assay was performed to confirm the interaction between miR-20a-5p and XIAP.
Results: NBP treatment significantly restored neurological function, reduced infarct size, and inhibited neuronal apoptosis. Mechanistically, NBP downregulated miR-20a-5p and upregulated XIAP. The protective effects of NBP were abolished by miR-20a-5p overexpression.
Conclusion: NBP exerts neuroprotective effects against CIRI by modulating the miR-20a-5p/XIAP axis. NBP may serve as a therapeutic agent for CIRI.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/01616412.2025.2539488 | DOI Listing |
Chem Biodivers
September 2025
School of Pharmaceutical Science, Yunnan Key Laboratory of Pharmacology for Natural Products/College of Modern Biomedical Industry, NHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, P. R. China.
20(R)-ginsenoside Rg3 can reduce the effects of oxidative stress and cell death in cerebral ischemia‒reperfusion injury (CIRI). Neuroinflammation is crucial post-CIRI, but how 20(R)-Rg3 affects ischemia‒reperfusion-induced neuroinflammation is unclear. To study 20(R)-Rg3's effects on neuroinflammation and neuronal preservation in stroke models and explore toll-like receptor 4/myeloid differentiation factor-88/nuclear factor kappa B (TLR4/MyD88/NF-κB) pathway mechanisms.
View Article and Find Full Text PDFNaunyn Schmiedebergs Arch Pharmacol
September 2025
Department of Pharmaceutics, Daqing Branch, Harbin Medical University, Daqing, China.
Transpl Immunol
September 2025
Intensive Care, Royal Free Hospital, Hampstead, London, United Kingdom.
Background: Inflammatory injury in organ donors, particularly after brain death and during ischemia-reperfusion, contributes to graft dysfunction, rejection, and reduced survival. Statins, beyond their lipid-lowering role, exert pleiotropic anti-inflammatory and immunomodulatory effects, including IL-6 suppression, NF-κB inhibition, immune cell modulation, and potential alteration of exosome secretion.
Methods: Building upon this background, this narrative review synthesises preclinical and clinical evidence on pre-donation statin therapy in solid organ transplantation.
J Biochem Mol Toxicol
September 2025
Department of Anesthesiology, Qianjiang Maternal and Child Health and Family Planning Service Centre, Qianjiang, Hubei, China.
Acute lung injury (ALI) is a major contributor to the high morbidity and mortality associated with intestinal ischemia-reperfusion (II/R). Despite its severity, current clinical management of ALI remains limited to supportive care without addressing the cause of the disease, underscoring the urgent need to investigate the underlying mechanism and develop targeted therapies. In this study, we employed both in vitro and in vivo models to explore ALI in the setting of II/R.
View Article and Find Full Text PDFJ Integr Neurosci
August 2025
Department of Neurology, Peking University First Hospital Taiyuan Hospital, 030000 Taiyuan, Shanxi, China.
Background: Remote ischemic conditioning (RIC), a novel neuroprotective therapy, has broad potential for reducing the occurrence and recurrence of cerebrovascular events, yet its mechanisms are not incompletely understood. The aim of this study is to investigate whether RIC alleviates apoptosis, inflammation, and reperfusion injury in rat models of ischemic stroke by regulating the Elabela (ELA)-apelin-Apelin receptor (APJ) system.
Methods: We established a rat model of middle cerebral artery occlusion (MCAO) with ischemia-reperfusion injury, and RIC was administered twice daily for 3 days post-MCAO.